SATELLOS BIOSCIENCE INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.42 CAD | -6.67% |
|
-8.70% | -2.33% |
| 03-27 | Satellos Bioscience Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 03-27 | Satellos Bioscience Announces FY 2023 Results | MT |
Chart calendar Satellos Bioscience Inc.
bb9f258012bef1fd624552.lYBjhbucIKCAZ5KLC0hmEtLPa6QkA9IadzlSjR9KpDw.oe1b79iuEc3aHuGyex8HfZmNNM9vZaZAMG03504B-2in-FHcjqlTzs44og~6e52fbaadef5e12458baf94a1b396219
Upcoming events on Satellos Bioscience Inc.
Past events on Satellos Bioscience Inc.
| 16/04/2024 16:30 | Bloom Burton & Co. Healthcare Investor Conference |
| 03/04/2024 16:30 | Cantor Fitzgerald Muscular Dystrophy Symposium - Fireside Chat |
| 27/03/2024 11:00 | Q4 2023 Earnings Release |
| 20/03/2024 12:00 | Stifel CNS Day - Fireside Chat |
| 10/03/2024 | Leerink Partners Global Biopharma Conference |
| 06/03/2024 17:30 | Muscular Dystrophy Association Clinical & Scientific Conference - SAT-3247 |
| 03/03/2024 23:00 | Muscular Dystrophy Association Clinical & Scientific Conference - Poster No : S46 |
| 29/11/2023 14:10 | Piper Sandler Healthcare Conference |
| 22/11/2023 12:00 | Q3 2023 Earnings Release |
| 14/11/2023 18:15 | Stifel Healthcare Conference |
| 27/09/2023 19:25 | Cantor Global Healthcare Conference |
| 29/08/2023 12:00 | Q2 2023 Earnings Release |
| 29/06/2023 16:00 | Annual General Meeting |
| 30/05/2023 22:45 | Q1 2023 Earnings Release |
| 31/03/2023 01:43 | Q4 2022 Earnings Release |
| 21/03/2023 16:40 | Muscular Dystrophy Association Clinical and Scientific Conference |
| 12/03/2023 | Business Update Call |
| 23/11/2022 22:41 | Q3 2022 Earnings Release |
| 17/10/2022 | Radius Research Investor Webinar |
| 14/10/2022 21:00 | World Muscle Society Meeting |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,10 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -6,27 -6,50 3.58% | -11,4 -8,30 -37.09% | -15,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -8,36 -6,50 -28.67% | -11,7 -8,40 -39.19% | -15,7 |
|
Net income Million USD | Released Forecast Spread | -8,37 -6,50 -28.73% | -11,7 -8,40 -39.19% | -15,7 |
|
EPS CAD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -0,19 |
| Announcement Date | 30/03/23 | 27/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | |
|
EBIT Million USD | Released Forecast Spread | -1,42 -1,80 21.15% | -1,59 -1,70 6.31% | -1,23 -1,70 27.7% | -3,21 -1,70 -88.78% | -3,27 -1,70 -92.21% | -4,60 -1,40 -228.4% | -4,04 | -3,85 | -3,89 | -3,93 | ||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -1,42 -1,80 21.25% | -3,74 -1,70 -120.24% | -1,22 -1,70 27.95% | -3,03 -1,70 -77.98% | -2,60 -1,70 -53.07% | -4,81 -1,40 -243.49% | -4,04 | -3,85 | -3,89 | -3,93 | ||
|
Net income Million USD | Released Forecast Spread | -1,72 | -1,42 -1,80 21.25% | -3,75 -1,70 -120.48% | -1,22 -1,70 27.95% | -3,03 -1,70 -77.98% | -2,60 -1,70 -53.07% | -4,81 -1,40 -243.49% | -4,04 | -3,85 | -3,89 | -3,93 | |
|
EPS CAD | Released Forecast Spread | -0,05 | -0,05 | -0,05 | -0,05 | -0,05 | |||||||
| Announcement Date | 29/08/22 | 23/11/22 | 30/03/23 | 30/05/23 | 28/08/23 | 22/11/23 | 27/03/24 | - | - | - | - | - |
More events
Past sector events for Satellos Bioscience Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MSCL Stock
- Calendar Satellos Bioscience Inc.
